Status:

TERMINATED

An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic Surgery

Lead Sponsor:

Janssen-Cilag Ltd.

Conditions:

Pain, Postoperative

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the mobilization characteristics, clinical use, safety and Ease of Care (EOC) of a fentanyl Iontophoretic Transdermal Patient Controlled Analgesia (PCA) system...

Detailed Description

This is a randomized (study drug assigned by chance), multicentre (when more than one hospital or medical school team work on a medical research study), open-label (participants and physicians are tol...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Participants, after an elective major abdominal or orthopedic (pertaining to bones) surgery
  • Expected to have acute (a quick and severe form of illness in its early stage) moderate (medium level of seriousness) to severe (very serious) post-operative pain requiring parenteral (administration by injection) opioids (morphine like medication) for at least 24 hours after surgery
  • Participants who have undergone General anesthesia (loss of sensation or feeling), spinal anesthesia of less than or equal to 4 hours duration or epidural (outside the spinal cord) anesthesia
  • Participants with respiratory rate 10 to 24 breaths per minute
  • Participants with a pain score less than or equal to 4 out of 10 on a Numerical Rating Scale (NRS), after titration to comfort with intravenous (IV) morphine Exclusion Criteria
  • Surgery secondary to malignancy (cancer or other progressively enlarging and spreading tumor) or trauma (injury)
  • History of psychological opioid dependence and/or known or suspected to be opioid dependent
  • Severe chronic (lasting a long time) obstructive respiratory symptoms susceptibility to respiratory depression, moderate to severe renal (having to do with the kidney) dysfunction
  • Peri-operative administration of opioids other than morphine, fentanyl, sufentanil, alfentanil or remifentanil
  • Require high doses of opioids to control their pain (more than 40 milligram morphine IV) during titration to comfort, or more than 6 hours have elapsed since the participant arrived in the recovery room or Monoamine oxidase inhibitors (MAOI) within 14 days pre-study

Exclusion

    Key Trial Info

    Start Date :

    May 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    September 1 2008

    Estimated Enrollment :

    108 Patients enrolled

    Trial Details

    Trial ID

    NCT00766506

    Start Date

    May 1 2008

    End Date

    September 1 2008

    Last Update

    April 25 2013

    Active Locations (7)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (7 locations)

    1

    Belfast, United Kingdom

    2

    Cardiff, United Kingdom

    3

    Edinburgh, United Kingdom

    4

    Glasgow, United Kingdom